baber/WOPTO huggingface dataset:
Patent MD-1526-B2 (MD)
Title: Bale retaining device
Inventor: WHITEHEAD ROGER
IPC: B66F9/18
Filed: 1993-03-11
Abstract: The invention relates to devices for maintaining, retaining and unpacking of loads, in particular of bales. The device contains an assembly framework (4) fixed on the forklift (1), a hoisting equipment (5), installed on the assembly framework (4) and provided with two retaining clamps (6, 7) mounted with the possibility of displacing across the movement direction towards each other and one from the other. At least one of retaining clamps (6, 7) is provided with a device (10) for cutting the wire tieing the bale round. The technical result consists in the possibility of cutting the wire tieing the bale round during the bale retaining process. Claims: 16 Fig.: 9
Patent AU-678646-B2 (AU)
Title: Grinding roller
Inventor: BRUNDIEK HORST DIPL ING
IPC: B02C15/00
Filed: 1995-01-03
Granted: 1997-06-05
Abstract: A grinding roller for roller or rolling mills, and its method for manufacture. For inexpensive manufacture and for increasing the service life, accompanied by limited repair expenditure, a roller jacket is manufactured in one piece for mounting on a radially inner roller body. The roller jacket has rated breaking points, along which the roller jacket breaks with radially directed breaking faces in the event of a corresponding stressing. By means of a holding device both the roller jacket manufactured in one piece and the optionally formed roller jacket breaking segments are fixed in an operationally safe manner.
Patent AU-775108-B2 (AU)
Title: Benzamide potassium channel inhibitors
Inventor: BAKER ROBERT K
IPC: A61P17/10
Filed: 1999-10-26
Granted: 2004-07-15
Abstract: This invention relates to benzamide potassium channel inhibitors of general structural Formula I.The compounds of this invention are useful in the treatment of autoimmune diseases, the prevention of rejection of foreign organ transplants and related afflictions, diseases and illnesses, and cardiac arrhythmias. Also within the scope of this invention are pharmaceutical formulations comprising a compound of Formula I and a pharmaceutical carrier, as well as pharmaceutical formulations comprising a compound of Formula I, one or more immunosuppressive compounds and a pharmaceutical carrier.
Patent AU-699631-B2 (AU)
Title: 5-(2-imidazolinylamino)benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agonists
Inventor: CUPPS THOMAS LEE
IPC: A61P11/00
Filed: 1994-12-15
Granted: 1998-12-10
Abstract: The subject invention involves compounds having the following structure:   <IMAGE>   wherein: (a) R is unsubstituted C1-C3 alkanyl or alkenyl; (b) R' is selected from hydrogen; unsubstituted C1-C3 alkanyl or alkenyl; unsubstituted C1-C3 alkylthio or alkoxy; hydroxy; thiol; cyano; and halo; and (c) R'' is selected from hydrogen, methyl, ethyl and i-propyl. The subject invention also involves pharmaceutical compositions containing such novel compounds, and the use of such compounds for preventing or treating respiratory, ocular and/or gastrointestinal disorders.
Patent AU-599289-B2 (AU)
Title: Hub configuration
Inventor: JENSEN BILLY M
IPC: A61M25/00
Filed: 1988-03-24
Granted: 1990-07-12
Abstract: This disclosure is a hub (11) which includes a resilient means (14) designed to engage the shank of a needle (16), cannula or stylet and resist axial movement therebetween while holding same therein. The configuration of the hub (11) allows the axial relationship between the needle, cannula or stylet and the hub (11) to be set and maintained during further assembly operations. Disclosed also is a method for assembling the needle, cannula or stylet to the specifically configured hub.
Patent AU-697750-B2 (AU)
Title: Method and control circuit for regulation of the operational characte ristics of gas discharge lamps
Inventor: PRIMISSER NORBERT
IPC: H05B41/392
Filed: 1997-01-16
Granted: 1998-10-15
Abstract: PCT No. PCT/EP97/00184 Sec. 371 Date Jul. 14, 1998 Sec. 102(e) Date Jul. 14, 1998 PCT Filed Jan. 16, 1997 PCT Pub. No. WO97/27726 PCT Pub. Date Jul. 31, 1997Gas discharge lamps are for regulated in a manner that is not affected by parasitic capacitances, such as line capacitances, by measuring current which passes through the lamp, calculating an active component of the measured current based on its phase in relation to a reference or by a comparison of the relative phases of the measured current and a voltage applied to the lamp, and regulating the lamp operation based on the active component.
Patent AU-699400-B2 (AU)
Title: Coiled tubing connector
Inventor: SMITH DONALD ALEXANDER
IPC: E21B17/04
Filed: 1995-05-01
Granted: 1998-12-03
Abstract: There is described a method and apparatus for connecting the end of coiled tubing (50) to a downhole tool string, comprising a first tubular housing (10) having a first uphole and a second downhole end and a bore formed therethrough for a length of coiled tubing, a second tubular housing (30) adapted for releasable connection to the downhole end of the first housing, the second housing having a first uphole and a second downhole end and a bore formed therethrough for receiving the length of coiled tubing at least partially into the second housing, slips (20) adapted to at least partially surround the coiled tubing and having on an inner surface thereof raised projections (23) for penetrating a contiguous surface of the coiled tubing for connection thereto, the slips (20) additionally including connectors (27) to interlock with cooperating connectors (33) on the second housing (30) for a non-rotatable torque transmitting connection therebetween, and a force transmitting member (15) disposed between the slips and the first housing to maintain the slips in compressive contact with the coiled tubing.
Patent AU-730263-B2 (AU)
Title: Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
Inventor: RIDGEWAY JAMES MADISON III
IPC: A61P29/00
Filed: 1997-01-30
Granted: 2001-03-01
Abstract: A compound having the structure:   <IMAGE>   wherein (a) n is from 1 to about 3; (b) X is selected from the group consisting of O, S, SO, or SO2; (c) Y is independently hydrogen or straight, branched or cyclic alkyl having from 1 to about 4 carbon atoms, or the Y's are bonded together to form an alkanyl ring having from about 3 to about 7 atoms; (d) Z is hydrogen or straight, branched or cyclic alkyl having from 3 to about 10 atoms other than hydrogen; (e) R1 is hydrogen or straight, branched or cyclic alkyl, aryl or C(=NH)-NHR4; and (f) R2, R3, and R4, are independently hydrogen, straight, branched or cyclic alkyl having from one to 10 carbon atoms, or aryl; R2 and R3 can be bonded together to form a ring having 5 or 6 atoms. pharmaceutical compositions comprising such compounds, and methods of treating inflammation or pain using such compounds.
Patent AU-663874-B2 (AU)
Title: Treatment of the musculoskeletal system
Inventor: MARKOLL RICHARD
IPC: A61N2/04
Filed: 1992-05-06
Granted: 1995-10-26
Abstract: The present invention relates to an apparatus for treating a body organ by applying a magnetic field by way of an annular coil (T) surrounding the body organ, wherein the apparatus comprises a horizontal transitional surface (14), supporting means for the body organ arranged within the opening of the coil and at least one track (26) arranged at a level below the supporting means for moving the coil and the supporting means relative to each other.
Patent AU-713482-B2 (AU)
Title: Reagents for specific binding assays
Inventor: KIAEI DAVID
IPC: G01N33/543
Filed: 1995-06-02
Granted: 1999-12-02
Abstract: A sensitive assay method has been discovered that reduces the amount of non-specific binding present in an assay, the method comprising detecting an analyte present in a sample through a specific binding reaction in which either an analogue of the analyte or a specific binding partner of the analyte is immobilized on a solid-phase and said specific binding reaction produces a detectable product immobilized on said solid-phase that may be correlated to the amount of analyte present in the sample wherein said assay employs an effective amount of a surfactant which is a polyoxyethylene-alkylether to reduce non-specific binding.
Patent AU-610253-B2 (AU)
Title: Sweet emulsion for chewing gum
Inventor: PATEL MANSUKH M
IPC: A23G4/00
Filed: 1988-07-20
Granted: 1991-05-16
Abstract: A method of adding a high intensity sweetener such as thaumatin, monellin and the like to chewing gum ingredients. The method comprises forming an emulsion comprising the high intensity sweetener, water, an emulsifier, and a hydrophobic ingredient which is preferably a flavor. Once formed, the emulsion is admixed with the chewing gum ingredients in any suitable manner.
Patent AU-782558-B2 (AU)
Title: Agents, such as nicotinamide or cADPR for the treatment of skin disorders
Inventor: HAREL AVIKAM
IPC: A61K8/60
Filed: 2001-01-09
Granted: 2005-08-11
Abstract: Methods and pharmaceutical compositions for use in the treatment of a benign and/or a malignant proliferative pathologies are disclosed. The methods comprise administration of nicotinamide or its analogs and/or cADPR or its analogs, optionally in combination with a vitamin D3 analog or a Vitamin A analog.
Patent AU-711197-B2 (AU)
Title: Methods and apparatus for surgical cutting
Inventor: EGGERS PHILIP E
IPC: A61B17/00
Filed: 1997-06-04
Granted: 1999-10-07
Abstract: An electrosurgical probe comprises a shaft having an electrode array (12) at its distal end and a connector at its proximal end. The array (12) includes a plurality of isolate electrode terminals, and an electrosurgical power supply (28) is provided with a multiplicity of independently limited or controlled current sources and a connector. The electrosurgical probe and the power supply may be connected through their respective connectors so that the independent current sources are connected to individual electrode terminals. By applying very high frequency electrical energy to the electrode array, target tissue may be cut or ablated while heat dissipation through low impedance paths, such as blood and normal saline, will be minimized. <IMAGE>
Patent AU-721648-B2 (AU)
Title: A moisture transport system for contact electrocoagulation
Inventor: TRUCKAI CSABA
IPC: A61B17/22
Filed: 1997-04-10
Granted: 2000-07-13
Abstract: The ablation device comprises an RF applicator head (2), a main body (4) and a handle (5). The main body includes a shaft (10). The RF applicator head includes an electrode carrier (12) mounted on the distal end of the shaft with an array of electrodes (14) formed on its surface. An RF generator is electrically connected to the electrodes to provide mono-polar or bipolar energy to them. The shaft is hollow and has a suction/insufflation tube (17) having a plurality of holes (17a) extending through it. An arched active spring (19) is connected between the distal end of a passive spring (15), attached to the distal end of the shaft, and the distal end of the tube. The electrode leads extend through the shaft.
Patent AU-684202-B2 (AU)
Title: Low temperature albumin fractionation using sodium caprylate as a partitioning agent
Inventor: TENOLD ROBERT A
IPC: C07K14/81
Filed: 1995-08-03
Granted: 1997-12-04
Abstract: Highly stable plasma-derived therapeutic albumin solutions, having a turbidity level of 5 NTU or less can be made by adding sodium caprylate to Cohn fraction II+III or IV-1 effluent at relatively low temperatures. The sodium caprylate acts as a partitioning agent to separate albumin from unwanted proteins. In preferred embodiments, the albumin source solution temperature is elevated, increased in pH and reacted for approximately six hours under conditions sufficient to disrupt the initial solution colloid, and partition albumin-containing supernatant from a colloidal disperse phase, which retains unwanted globulins and manufacturing debris. Since it tends to be a scavenger molecule, albumin is selectively stabilized by diafiltration against a buffer containing sodium caprylate, thereby assuring a high albumin monomer content and low turbidity level. The amount of sodium caprylate required for selective stabilization is determined by the amount of available binding sites on the albumin molecule.
Patent AU-734131-B2 (AU)
Title: Self-adhesively treated backing materials
Inventor: HIMMELSBACH PETER
IPC: C09J7/38
Filed: 1997-07-17
Granted: 2001-06-07
Abstract: Substrate materials, coated on at least one side with a pressure-sensitive adhesive comprising a hot-melt adhesive material that has a dynamic complex Tg < -3 (-9 to -25) degrees C at a frequency of 0.1 rad/s. Preferably the adhesive contains a block copolymer, preferably of the A-B or A-B-A type, or a mixture of these, in which A is polystyrene or a derivative thereof and B is propylene, butadiene or isoprene, or mixtures of these, preferably ethylene and/or butylene. Styrene content in the polymer is less than 35 (5-30) wt.%. The adhesive comprises 10-90 wt.% block copolymer, 5-80 wt.% tackifier (eg. oil, wax or resin, or a mixture of these, preferably a resin/oil mixture), less than 60 wt.% emulsifier, less than 15 wt.% additives and less than 5 wt.% stabiliser.
Patent AU-647010-B2 (AU)
Title: Improvements relating to drinking vessels
Inventor: BETKA MALCOLM
IPC: B65D41/00
Filed: 1988-12-28
Granted: 1994-03-17
Abstract: A drinking vessel has a cylindrical body (1) forming the main receptacle, and a lid (2) with a snap fit over the rim of the body. The lid has a mouthpiece (6) diametrically opposed to a vent (8) and when turned to one position both are blocked. But when turned to another position, both are opened to the interior of the body (1) by ducts (11) in an inner flange (10) of the lid registering with recesses (5) in the rim of the body.
Patent AU-715722-B2 (AU)
Title: Distributed excimer laser surgery system
Inventor: HOHLA KRISTIAN
IPC: A61F9/01
Filed: 1997-05-26
Granted: 2000-02-10
Abstract: A distributed system is provided for controlling excimer laser eye surgery. A topography system, a computer system, and an excimer laser eye surgery system are provided, with the topography system providing profile data to the computer system, and the computer system calculating and providing an ablation shot pattern to the excimer laser eye surgery system. At least the computer system and the excimer laser eye surgery system are located remotely, and the excimer laser eye surgery system can receive data from more than one computer system and more than one topography system. This allows for better utilization of resources.
Patent AU-692298-B2 (AU)
Title: Recombinant thermostable enzyme for converting maltose into trehalose
Inventor: TSUSAKI KEIJI
IPC: C12N1/21
Filed: 1995-10-02
Granted: 1998-06-04
Abstract: Disclosed are a recombinant thermostable enzyme, which converts maltose into trehalose and is stable up to a temperature of about 80 DEG C even when incubated at pH 7.0 for 60 min, a preparation of the enzyme, a DNA encoding the enzyme, a recombinant DNA containing the DNA, a transformant, and an enzymatic conversion method of maltose by using the enzyme.
Patent AU-684711-B2 (AU)
Title: Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and oedema
Inventor: NAKAMURA-CRAIG MEIRE
IPC: A61K31/53
Filed: 1993-02-18
Granted: 1998-01-08
Abstract: The present invention relates to the use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine and its pharmaceutically and veterinarily acceptable acid addition salts in therapy.
Patent AU-655723-B2 (AU)
Title: Human antithrombin III mutant
Inventor: KATO HIROYUKI
IPC: A61K38/00
Filed: 1993-04-06
Granted: 1995-01-05
Abstract: A novel human antithrombin III (AT III) mutant having a high antithrombin activity in the absence of heparin and effective in the treatment of thrombotic disorders as an anticoagulant, which is obtained by mutating amino acids at the reactive site and the heparin binding site of human AT III into another amino acids with the use of the recombinant DNA technology with the use of a DNA coding for AT III as a template. A method for mass producing the above-described mutant by incubating a host transformed by an expression vector having the cDNA of the mutant inserted therein.
Patent AU-727606-B2 (AU)
Title: Gamma-heregulin
Inventor: SCHAEFER GABRIELE M
IPC: A61K38/00
Filed: 1997-07-08
Granted: 2000-12-14
Abstract: Chimeric heteromultimer adhesins that bind the ligand of natural heromultimeric receptors and uses therefor are disclosed. The chimeric molecules of the heteromultimer adhesins comprise an extracellular domain of a heteromultimeric receptor monomer and a multimerization domain for the stable interaction of the chimeric molecules in the adhesin. Specifically disclosed are heteromultimeric adhesins comprising the extracellular domains of the ErbB2 and ErbB3 and ErbB2 and ErbB4. The chimeric ErB heteromultimer adhesins of the present invention are useful as competitive antagonists or agonists of a neuregulin for the treatment of diseases such as various cancers.
Patent AU-729532-B2 (AU)
Title: Melatonin 1a receptor gene regulatory regions and uses thereof
Inventor: REPPERT STEVEN M
IPC: C12N15/09
Filed: 1997-07-17
Granted: 2001-02-01
Abstract: Disclosed are DNAs encoding melatonin 1a receptor gene promoter regions, recombinant polypeptides expressed from such DNAs, and methods of using such expression constructs to screen for promoter activators or inhibitors. Transcriptional activators are useful as therapeutics to reentrain endogenous melatonin rhythms as a means of treating circadian rhythm disorders in humans and control reproductive cycles in seasonally breeding animals. Transcriptional inhibitors are useful as therapeutics to control the initiation or timing of puberty in humans.
Patent AU-630613-B2 (AU)
Title: A method of using thiocarbamoyl retinoid analogues and pharmaceutical compositions containing them
Inventor: BRYCE GRAEME FINDLAY
IPC: C07C333/04
Filed: 1989-07-13
Granted: 1992-11-05
Abstract: Compounds of formula I can be used as topical agents to combat the disorders of the skin produced by photodamage which disorders include: wrinkling, elastosis and premature aging. Compounds of formula I are <CHEM> wherein n represents 1 or 2, R represents mono- or di-(lower alkyl)carbamoyl.
Patent AU-577838-B2 (AU)
Title: Knife sharpener
Inventor: FRIEL DANIEL D
IPC: B24B3/54
Filed: 1985-03-11
Granted: 1988-10-06
Abstract: 0 A method and apparatus for sharpening knives, blades, and the like utilizing a rotating displaceable abrasive disk where the abrading force on the knife cutting edge facet in parallel contact with the surface of the disk perpendicular to its axis of rotation is controlled by a biasing means such as a spring or equivalent, the position of the cutting edge facet on the disk is established by two appropriate stops contiguous to the disk and the angle between the principal plane of the disk and the face of the knife is controlled precisely so as to accommodate knives of different thickness and shape. Magnetic means to control the angle are claimed. Methods and apparatus include sequential steps that utilize one or more orbiting abrasive surfaces together with an abrasive disk sharpener where in each step there is a guide, preferably magnetic, to control the sharpening angle and where the angle is progressively greater in those sharpening steps where the orbiting abrasive elements are employed. Also claimed are means in a disk sharpener to prevent accidental contact of the face of the blade with the moving abrasive surface.
Patent AU-579368-B2 (AU)
Title: Process for preparing naproxen and intermediates useful in the said process
Inventor: VISENTIN GIUSEPPINA
IPC: C07C69/734
Filed: 1985-05-06
Granted: 1988-11-24
Abstract: Process for preparing Naproxen via a sequence of a stereospecific reactions which comprises: condensation of 1-chloro-2-methoxy-naphthalene with a (S)-2-halo-propionyl halide according to the Friedel-Crafts reaction, ketalization of the thus obtained (S)-2-halo-1-(5'-chloro-6'-methoxy-2'-naphthyl)-propan-1-one, rearrangement of said ketal to aford an ester, hydrolysis of the ester and removal of the chlorine atom in 5-position by hydrogenolysis.New (S) 2-halo-1-(5'-chloro-6'-methoxy-2'-naphthyl)-propan-1-ones.
Patent AU-664465-B2 (AU)
Title: A method and a device for correlating two or more optical pulse signals
Inventor: THOGERSEN JAN
IPC: G06E3/00
Filed: 1993-06-15
Granted: 1995-11-16
Abstract: The object of the invention is to provide a method which makes it possible to determine the correlation between two optical signals, which makes it possible to correlate two optical signals, without using a crystal element which is associated with a plurality of drawbacks, because the components are quite expensive. It has been found possible to replace a frequency doubling crystal by an active, optical wave guide, e.g. in the form of an active, optical fiber, said wave guide transmitting fluorescence which is intensity-related to the arrived signal. When this fluorescence is detected in spectral bands, e.g. in the blue region of the visible light, an image of the strength of the arriving signal may be formed. Current distance delaying of the two correlated signals makes it possible to produce an image of the correlation between the signals.
Patent AU-666388-B2 (AU)
Title: Novel cytokine that binds CD30
Inventor: GOODWIN RAYMOND G
IPC: C07K16/28
Filed: 1993-05-25
Granted: 1996-02-08
Abstract: There is disclosed a polypeptide (CD30-L) and DNA sequences, vectors and transformed host cells useful in providing CD30-L polypeptides. The CD30-L polypeptide binds to the receptor known as CD30, which is expressed on a number of cell types, among which are Hodgkin's Disease tumor cells, large cell anaplastic lymphoma cells, adult T-cell leukemia (T-ALL) cells, and a number of other malignant cell types. CD30-L polypeptides find use as carriers for delivering diagnostic and cytotoxic agents to cells expressing the CD30 receptor.
Patent AU-627785-B2 (AU)
Title: Vasopermeability-enhancing conjugates
Inventor: EPSTEIN ALAN L
IPC: A61K51/10
Filed: 1989-10-11
Granted: 1992-09-03
Abstract: Conjugates having a clinically useful delivery vehicle linked to a biologically active species which acts to increase vascular permeability and expand blood volume at or in proximity to the tumor site are disclosed. The vehicle-linked species may be, for example, a vasoactive agent, a substance that recruits or amplifies a vasoactive species, a toxin, a drug, an isotope, or a pharmaceutical compound. Suitable biological species comprises peptides, lipids, carbohydrates, or their derivatives. Chemical or recombinant DNA methods suitable for linking the species to the vehicles are indicated. A therapy is disclosed which comprises administering the vasoactive conjugate and delivering a diagnostic agent or a therapeutic agent at an optimal time thereafter, when tumor vasculature is maximally expanded.
Patent AU-705896-B2 (AU)
Title: Decolorization of polysuccinimide
Inventor: MARTIN DAVID ALBERT
IPC: C08G69/10
Filed: 1995-12-21
Granted: 1999-06-03
Abstract: There is disclosed a process for decolorizing polysuccinimide by means of contacting the polysuccinimide in the solid state with an aqueous solution of a bleach. Typically, polysuccinimide is placed into a solution of hydrogen peroxide to form a slurry with solid particles whereby the color of the polysuccinimide is greatly reduced. Separation of the bleach solution is performed easily by means of solid liquid separation such as by filtration rendering the polysuccinimide acceptable for use directly into detergent formulations.
Patent AU-724931-B2 (AU)
Title: A process for isolating insulin by high-pressure liquid chromatography
Inventor: OBERMEIER RAINER
IPC: C07K14/62
Filed: 1997-12-16
Granted: 2000-10-05
Abstract: Isolation of insulin by chromatography is carried out using a pressure-stable acidic cation exchanger at a pressure of 1.1-40 MPa.